Product Detail

Current Location: Home> IVD Raw Materials>Respiratory Series>Raw Materials of Influenza B
Raw Materials of Influenza B

Synonym: Influenza B product

Species: Influenza B virus

Protein Accession: P03459

Purity: >= 95%

Endotoxin Level: < 1.0 EU per μg of protein

Biological Activity: N/A

Expression System: Mammalian cells

Fusion Tag: None

Predicted Molecular Mass: 30 kDa

Formulation: Lyophilized

Reconstitution: Reconstitute in sterile water

Storage & Stability: Store at -20°C upon receipt, stable for up to one year

FAQ

Q: What are the raw materials of Influenza B and their significance in the feed industry?

The raw materials of Influenza B can broadly include various biological elements necessary for vaccine production or scientific research. In the feed industry, these materials hold significance especially in the form of additives that can help in the development of more robust immune systems in livestock. This is crucial for preventing widespread illnesses and maintaining the health and productivity of animals. By incorporating such raw materials into feed formulations, producers may improve resistance to respiratory diseases, thereby ensuring a healthier stock of animals.

Q: How do the raw materials of Influenza B enhance animal health in the feed industry?

Raw materials derived from Influenza B can provide essential bioactive compounds that stimulate the immune system of animals. When included in animal feed, these materials can help create a preemptive defense mechanism against respiratory diseases similar to or deriving from strains related to Influenza B. Proper incorporation can lead to stronger mucosal immunity in the nasal passages and respiratory tract, minimizing the likelihood of widespread infections within a farming community. This biotechnological advancement is crucial for large-scale operations, where disease prevention translates directly to lower mortality rates and higher productivity.

Q: Are there any safety concerns associated with using Influenza B raw materials in animal feed?

The safety of using Influenza B raw materials in animal feed is always a primary concern. They must undergo rigorous testing to ensure they do not pose any risk to animal health or, subsequently, to humans who might consume products such as meat, milk, or eggs derived from these animals. Regulatory agencies like the FDA or the equivalent agricultural boards in various countries mandate stringent standards for safety and efficacy. When these raw materials are properly vetted and approved, there is a sustained assurance that they are safe for consumption and do not carry harmful pathogens or contaminants.

Q: What benefits do feed manufacturers experience by incorporating Influenza B raw materials in their products?

For feed manufacturers, incorporating raw materials of Influenza B can yield multiple advantages. Primarily, it can differentiate their products in the marketplace by offering a scientifically-backed addition aimed at enhancing animal health and immunity. This can provide a competitive edge, allowing manufacturers to cater to a market increasingly concerned with animal welfare and health. Moreover, healthier livestock means higher productivity and lower healthcare costs for producers, which further reinforces the value proposition of these enhanced feed products. Long-term benefits also include building a reputation for innovation and commitment to quality in the feed industry.

Q: How is the incorporation of Influenza B raw materials monitored to ensure consistency and effectiveness?

The incorporation of Influenza B raw materials in animal feed is stringently monitored at multiple stages. To ensure consistency and effectiveness, manufacturers often follow a standardized protocol encompassing quality assurance measures from procurement to final production. This involves sourcing raw materials from certified vendors, conducting batch testing for potency and purity, and adherence to formulation guidelines. Furthermore, post-production, the feed undergoes routine sample testing to confirm the concentration of the active ingredients, ensuring they meet the required benchmarks for effectiveness. Such comprehensive monitoring is essential to maintain the integrity of the product and uphold the trust of the consumers in the feed industry.

Jiangsu East-Mab Biomedical Technology Co.,Ltd

contact us

Factory address:
Life and Health Industrial Park, Rudong County, Nantong City, Jiangsu Province

Contact: Fred Wang
Tel: 0086-25-52397805
Phone/WhatsApp: 0086-18005193850

mobile
Jiangsu East-Mab Biomedical Technology Co.,Ltd

Copyright(C)2023,Jiangsu East-Mab Biomedical Technology Co.,Ltd All Rights Reserved.

Leave A Message
Leave A Message ×
If you are interested in our products and want to know more details,please leave a message here,we will reply you as soon as we can.